Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
AntionkoRAN-M by Gene Surgery for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
AntionkoRAN-M is under clinical development by Gene Surgery and currently in Phase I for Head And Neck Squamous Cell Carcinoma...
AntionkoRAN-M by Gene Surgery for Penile Cancer: Likelihood of Approval
AntionkoRAN-M is under clinical development by Gene Surgery and currently in Phase I for Penile Cancer. According to GlobalData, Phase...
AntionkoRAN-M by Gene Surgery for Vulvar Cancer: Likelihood of Approval
AntionkoRAN-M is under clinical development by Gene Surgery and currently in Phase I for Vulvar Cancer. According to GlobalData, Phase...
AntionkoRAN-M by Gene Surgery for Solid Tumor: Likelihood of Approval
AntionkoRAN-M is under clinical development by Gene Surgery and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
AntionkoRAN-M by Gene Surgery for Anal Cancer: Likelihood of Approval
AntionkoRAN-M is under clinical development by Gene Surgery and currently in Phase I for Anal Cancer. According to GlobalData, Phase...
AntionkoRAN-M by Gene Surgery for Cervical Cancer: Likelihood of Approval
AntionkoRAN-M is under clinical development by Gene Surgery and currently in Phase I for Cervical Cancer. According to GlobalData, Phase...
AntionkoRAN-M by Gene Surgery for Melanoma: Likelihood of Approval
AntionkoRAN-M is under clinical development by Gene Surgery and currently in Phase I for Melanoma. According to GlobalData, Phase I...
AntionkoRAN-M by Gene Surgery for Breast Cancer: Likelihood of Approval
AntionkoRAN-M is under clinical development by Gene Surgery and currently in Phase I for Breast Cancer. According to GlobalData, Phase...